MedTrace Logo

Deep Brain Stimulation (DBS) Retrospective Outcomes Study

NCT03664609 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 5000

Last updated 2026-05-06

No results posted yet for this study

Summary

The primary objective of this study is to characterize real-world clinical outcomes of Deep Brain Stimulation (DBS) using retrospective review of de-identified patient records.

Conditions

Interventions

DEVICE

Deep Brain Stimulation

Deep Brain Stimulation in patients with Parkinson Disease, Dystonia and Essential Tremor.

Sponsors & Collaborators

  • Boston Scientific Corporation

    lead INDUSTRY

Principal Investigators

  • Natalie Bloom Lyons · Boston Scientific Neuromodulation Corporation

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-03-12
Primary Completion
2028-12-31
Completion
2028-12-31
FDA Device
Yes

Countries

  • United States
  • Belgium
  • France
  • Germany
  • Italy
  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03664609 on ClinicalTrials.gov